Search

Your search keyword '"Barker, Frederick G"' showing total 119 results

Search Constraints

Start Over You searched for: Author "Barker, Frederick G" Remove constraint Author: "Barker, Frederick G"
119 results on '"Barker, Frederick G"'

Search Results

1. Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.

2. Alliance A071401: Phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations.

3. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas

4. Rationale for the Development of a Novel Clinical Grading Scale for Postoperative Facial Nerve Function: Results of a Multidisciplinary International Working Group

5. American Neurotology Society, American Otological Society, and American Academy of Otolaryngology – Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic

6. Supplementary Table S1 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

7. Data from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

8. Supplementary Methods, Figures S1 - S20 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

9. Supplementary File 3 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

10. Supplementary File Legends from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

11. Supplementary File 2 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

12. Supplementary File 1 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

13. Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis:A Case Series

15. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

16. Vestibular Schwannomas

17. EXTH-89. EXPLORING ANTI-TUMOR EFFECTS OF SMALL MOLECULE INHIBITORS OF CDK4/6, FAK, AND RAF/MEK IN PRECLINICAL MODELS OF MENINGIOMA

20. The 1994 National Cancer Institute’s strategy to fund multi-institutional, multidisciplinary consortia to design and conduct early phase clinical trials in patients with high grade gliomas.

21. Multi-center, single arm phase II study of the dual mTORC1/mTORC2 inhibitor vistusertib for patients with recurrent or progressive grade II-III meningiomas.

24. Contributors

26. Contributors

29. Vestibular Schwannomas

30. Contributors

32. Working Toward Consensus on Sporadic Vestibular Schwannoma Care: A Modified Delphi Study

34. Alliance A071701: Genomically guided treatment trial in brain metastases.

40. Super-resolution Diffusion Tensor Imaging for Delineating the Facial Nerve in Patients with Vestibular Schwannoma

41. Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas

45. 116 Exome Sequencing Uncovers Molecular Determinants of Trigeminal Neuralgia

46. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas

47. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

48. NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases.

49. Contributors

Catalog

Books, media, physical & digital resources